SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950134-04-006252
Filing Date
2004-04-29
Accepted
2004-04-29 17:03:39
Documents
3
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K f98395a1e10vkza.htm 10-K/A 93973
2 EXHIBIT 31.3 f98395a1exv31w3.htm EX-31.3 2533
3 EXHIBIT 31.4 f98395a1exv31w4.htm EX-31.4 2640
  Complete submission text file 0000950134-04-006252.txt   100885
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-22570 | Film No.: 04765930
SIC: 2833 Medicinal Chemicals & Botanical Products